Effects of rilmenidine on signal transduction mechanisms associated with alpha 2-adrenergic and imidazoline receptors in brain.
Regunathan
S
S
Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York 10021, USA.
Bramwell
S
S
Reis
D J
DJ
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D001933:Brain Stem / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D000242:Cyclic AMP / Q000096:biosynthesis; D006152:Cyclic GMP / Q000096:biosynthesis; D054755:Imidazoline Receptors; D066298:In Vitro Techniques; D017136:Ion Transport; D010080:Oxazoles / Q000494:pharmacology*; D010716:Phosphatidylinositols / Q000378:metabolism; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D000077769:Rilmenidine; D012413:Rubidium / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists; D054755:Imidazoline Receptors; D010080:Oxazoles; D010716:Phosphatidylinositols; D011955:Receptors, Drug; D000242:Cyclic AMP; D006152:Cyclic GMP; D012413:Rubidium; D000077769:Rilmenidine; D002118:Calcium